TSRO

TESARO Inc

TESARO Inc is a leading biopharmaceutical company that specializes in developing and commercializing innovative cancer treatments. Our mission is to enhance the quality of life for cancer patients by providing them with access to cutting-edge therapies that target the underlying mechanisms of their disease. Our portfolio includes a range of products that target different types of cancer, such as ovarian, lung, and breast cancer. Our flagship product, Zejula, is a PARP inhibitor that has been approved for the treatment of ovarian cancer. We are committed to advancing the science of cancer treatment through research and development, and have a strong pipeline of new therapies in various stages of development. Headquartered in Waltham, Massachusetts, we have operations in Europe and Asia. At TESARO, we are dedicated to making a meaningful difference in the lives of cancer patients worldwide.

Instrument specification in OANDA

Name
Valūta
Simbols
Minimālā pasūtījuma vērtība
Ticker
Tirdzniecības laiks
Type
Pasūtījumu pieņemšanas laiks
ISIN

Sāciet tirgot tagad ar ātru konta atvēršanu.

Reģistrējieties tagad, lai tirgotos aktīvākajos tirgos

ATVER KONTU
OANDA ir vairāk nekā 20 gadus tirgū strādājošs brokeris, kas lepojas ar vadošajiem analīzes rīkiem un tūkstošiem apmierinātu klientu, un ir godalgots starpnieks.
Iegūstiet piekļuvi visaktīvākajiem pasaules tirgiem ar tūkstošiem tirdzniecības instrumentu, kā arī vadošajiem tehniskajiem rīkiem, kas palīdz veikt analīzi.
Tirdzniecība bez liekām izmaksām un pilnīga cenu pārredzamība - OANDA piedāvā nulles komisijas maksu par galvenajiem instrumentiem un pārredzamu cenu noteikšanu.
Scroll to top